Thank you!

BU issues Marathon advice to students: No Animal Housing in the GAP and for God's sake, stay away from parties at BC if you can't handle your liquor
www.universalhub.com/2026/bu-issu...

#Boston #PatriotsDay

This is my favorite climate change chart. Japanese monks, aristocrats, and emperors kept meticulous records of cherry blossom festivals for 1,200 years and accidentally built the world's longest climate dataset.

Long COVID studies stymied by pharma’s lack of cooperation Academic researchers want to repurpose drugs for the condition. Manufacturers aren’t supplying them

Read the article here: cen.acs.org/pharmaceutic...

Many, many thanks to the researchers who helped me illuminate this problem--which, by the way, is ongoing--and to the team at C&EN, not least my editor @laurahowes.bsky.social and visuals editor Madeline Monroe who created an awesome illustration for the piece

I'm proud to share that an article I published in @cenmag.bsky.social last February, "Long COVID studies stymied by pharma's lack of cooperation," has been selected as a finalist in the trade journalism category of the @nihcm.bsky.social Journalism Awards:

Lilly to buy narcolepsy drug developer for $6.3 billion The pharma giant has agreed to acquire Centessa Pharmaceuticals

Lilly's acquisition of Centessa Pharmaceuticals is the third-largest biopharma acquisition of the year so far. $LLY $CNTA cen.acs.org/business/mer... @cenmag.bsky.social

A new COVID variant is spreading in the U.S. How worried should you be? Infections of the BA.3.2 variant of the COVID-causing coronavirus are still at very low levels, but experts are concerned it may be resistant to immunity from vaccines or prior infection

Infections of the BA.3.2 variant of the COVID-causing coronavirus are still at very low levels, but experts are concerned it may be resistant to immunity from vaccines or prior infection

I'll be at BIO this June. Relatedly, it's so hard to imagine traveling to San Diego just to hang out in the convention center. Who wants to meet with me at the Point Loma tide pools? #biosky

RECOVER-TLC is hosting another webinar today, sharing updates on the Long COVID clinical trials program. I will do some live blogging here and might have further writing at @thesicktimes.org (if they share anything newsworthy).

Announcing the Retraction Watch Research Accountability Reporting Fellowship - The Open Notebook The Open Notebook and Retraction Watch are thrilled to announce a new fellowship program funded by The Center for Scientific Integrity. This six-month program will equip up to six reporters and editors at local newsrooms to report stories of scientific integrity unfolding at research universities or institutions in their areas.

New Fellowship Alert: Our colleagues at The Open Notebook are partnering with Retraction Watch to offer up to six $7,500 fellowships + training to support reporting on local issues of scientific accountability.

Learn more and register for the Mar 26 informational webinar:

Shanghai start-up launches to develop trispecific antibodies Excalipoint Therapeutics has raised $68.7 million

A new start-up is launching out of Shanghai with $68.7 million and a plan to tackle cancer and autoimmune diseases with T-cell-engaging antibodies.

cen.acs.org/pharmaceutic...

@cenmag.bsky.social #chemsky #biosky

Relief and unease as court overturns RFK vaccine policies Recent changes to US childhood vaccine schedule will not stand

With @maxhenrybarnhart.bsky.social in @cenmag.bsky.social cen.acs.org/pharmaceutic...

Many health scientists and practitioners are breathing a sigh of relief following a court decision that effectively reversed every change to US vaccine policy made since RFK took office last February. But for many children, irreversible damage has already been done.

In like a lamb, out like a lion, and presumably the middle is some horrible lamb/lion chimera

The Chemical & Engineering News Guild has overwhelmingly won its union election, with 96% of participants voting in favor of unionization!

@wbng.org @newsguild.org

FDA says it wants individualized medicines. Can we get there? The agency has announced a new framework for approving rare disease drugs, but investors are still skeptical

With @laureloldach.bsky.social in @cenmag.bsky.social cen.acs.org/pharmaceutic...

"I think that there’s a lack of really trusting that this pathway that’s commercially viable for individualized medicine is really going to open up. If investors don’t believe in it, there are no companies in this space. The companies won’t last." Julia Vitarello, patient advocate and founder, EveryONE Medicines

The FDA recently described a new regulatory framework that would let personalized medicines with a “plausible mechanism” of action bypass randomized clinical trials.

But recent decisions about rare disease drug applications raise doubts about what the pathway means for patients.

#chemsky #biosky

FDA says it wants individualized medicines. Can we get there? The agency has announced a new framework for approving rare disease drugs, but investors are still skeptical

In light of FDA's recent announcement of new regulatory flexibility for individualized medicines that work through a "plausible mechanism," @rowanwalrath.bsky.social and I dug into what the agency is saying, what it's doing, and what's at stake for ppl w/ rare diseases.

cen.acs.org/pharmaceutic...

FDA says it wants individualized medicines. Can we get there? The agency has announced a new framework for approving rare disease drugs, but investors are still skeptical

The FDA recently announced a new regulatory framework that would let personalized medicines with a “plausible mechanism” of action bypass randomized clinical trials.
For @cenmag.bsky.social, @rowanwalrath.bsky.social and @laureloldach.bsky.social dig into it

I haven't solved the epistemic crisis since we last talked, unfortunately

MAHA’s next target: metals in vaccine ingredients Officials are going after metal-containing ingredients, including aluminum adjuvants. Here’s why vaccines need them

My colleagues @rowanwalrath.bsky.social and @sarahbraner.bsky.social dug into what we know about how alum and related adjuvants stimulate immunity and why MAHA regulators are going after them.

cen.acs.org/pharmaceutic...

US vaccine recommendations used to be based in science. Now it’s all vibes The Evidence to Recommendations framework ensured that the US vaccine schedule was scientifically sound. Then RFK Jr. abandoned it

In the past, the US Advisory Committee on Immunization practices used a detailed, scientific methodology to assess vaccine data before making a recommendation. Now that process “has completely been circumvented,” under RFK Jr. @rowanwalrath.bsky.social and I have the details for @cenmag.bsky.social.

Controversial US study on hepatitis B vaccines in Africa is cancelled $1.6m project drew outrage over ethical questions about withholding vaccines proven to prevent disease

Controversial US study on hepatitis B vaccines in Africa is cancelled. Story by @melodyschreiber.com www.theguardian.com/us-news/2026...

The essential chemistry newsletter. A concise weekly briefing from C&EN, covering the research, policy, and industry developments that matter most to chemists.

C&EN’s Weekly Newsletter has evolved. Meet C&EN Elements, redesigned to deliver the essential developments in chemistry across research, industry, and policy: connect.discoveracs.org/weeklynewsle...

#chemsky 🧪

Despite few big announcements at JPM, biotech investors optimistic Discussions not deals on the first day of the J.P. Morgan Healthcare Conference in San Francisco

Discussions not deals on JPM day one: cen.acs.org/pharmaceutic... @cenmag.bsky.social #chemsky #biosky

Ensures that all the diseases covered by the previous immunization schedule will still be available to anyone who wants them through Affordable Care Act insurance plans and federal insurance programs, including Medicaid, the Children’s Health Insurance Program, and the Vaccines for Children program. Families will not have to purchase them out of pocket. Among peer nations, the U.S. will continue to offer the most childhood vaccines for free to those who want them.

Copy Editing Matters, from HHS's release on the new childhood vaccine schedule: All the diseases will still be available to anyone who wants them

Congratulations to the amazing C&EN staff!

As C&EN Advisory Board member, whose mission is to “provide insight, advice, and suggestions on how to best serve our audience and the world of chemistry”, I believe this is a good step toward a stronger magazine.

6 shots removed from US childhood vaccine recommendations Several immunizations now need a health-care provider’s endorsement

The new CDC schedule no longer universally recommends immunizations against meningitis, hepatitis A and B, respiratory syncytial virus (RSV), rotavirus, COVID-19, and influenza.

cen.acs.org/pharmaceutic...

Long live c&en and everyone who brings us quality stories about chemistry